Australia markets closed

Tibet Weixinkang Medicine Co., Ltd. (603676.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
8.22+0.22 (+2.75%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,290,108
1,322,649
1,398,543
1,033,623
715,667
Cost of revenue
621,219
650,548
662,875
500,401
384,116
Gross profit
668,889
672,101
735,668
533,221
331,551
Operating expenses
Research development
121,656
112,820
72,453
38,019
23,195
Selling general and administrative
286,583
297,677
386,333
316,561
204,739
Total operating expenses
523,727
526,666
568,483
435,836
286,227
Operating income or loss
145,162
145,435
167,185
97,386
45,324
Interest expense
347.5944
342.287
189.5153
114.8015
-
Income before tax
255,930
215,838
182,355
114,228
69,620
Income tax expense
7,245
1,821
5,397
18,317
11,195
Income from continuing operations
248,685
214,017
176,958
95,911
58,425
Net income
248,685
214,017
176,958
95,911
58,425
Net income available to common shareholders
248,685
214,017
176,958
95,911
58,425
Basic EPS
0.55
0.50
0.41
0.23
0.14
Diluted EPS
0.55
0.50
0.41
0.23
0.14
Basic average shares
429,858
428,034
431,606
417,005
417,320
Diluted average shares
429,858
428,034
431,606
417,005
417,320